OMED

OncoMed Pharmaceuticals, Inc.

OMED

Delisted

OMED was delisted on the 22nd of April, 2019.

62 hedge funds and large institutions have $143M invested in OncoMed Pharmaceuticals, Inc. in 2014 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 26 increasing their positions, 21 reducing their positions, and 7 closing their positions.

2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1 2016 Q4 2016 Q3 2016 Q2 2016 Q1 2015 Q4 2015 Q3 2015 Q2 2015 Q1 2014 Q4 2014 Q3 2014 Q2 2014 Q1 2013 Q4 2013 Q3

Holders

Holders Change

-1

Holders Change %

-1.59%

% of All Funds

1.8%

Holding in Top 10

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

0.03%

New

Increased

Reduced

Closed

Calls

$1.84M

Puts

$295K

Net Calls

+$1.54M

Net Calls Change

+$1.54M

Top Buyers

1	BI 1 BVF Inc San Francisco, California	$24.4M
2	SAM 2 Sectoral Asset Management Montreal, Quebec, Canada	$32.1M
3	CIP 3 Convergence Investment Partners Palm Beach Gardens, Florida	$2.12M
4	4 T. Rowe Price Associates Baltimore, Maryland	$2.42M
5	5 Northern Trust Chicago, Illinois	$2.54M

Top Sellers

1	CCI 1 Columbus Circle Investors	$0
2	2 Primecap Management Pasadena, California	$4.13M
3	BIT 3 BlackRock Institutional Trust San Francisco, California	$2.41M
4	4 Invesco Atlanta, Georgia	$0
5	5 Renaissance Technologies New York	$759K

#	Name	Market Value	Shares	Shares Change	Shares Change %
26	26 JPMorgan Chase & Co New York	$829K	43,785	+21,071	+93%
27	TAM 27 Tocqueville Asset Management New York	$802K	42,350	-800	-2%
28	28 Renaissance Technologies New York	$759K	40,110	-19,090	-32%
29	BIM 29 BlackRock Investment Management Wilmington, Delaware	$700K	36,960	+855	+2%
30	SO 30 STRS Ohio Columbus, Ohio	$593K	31,347	+27,347	+684%
31	31 Charles Schwab San Francisco, California	$545K	28,777	+6,012	+26%
32	GT 32 Glenmede Trust Philadelphia, Pennsylvania	$543K	28,700	–	–
33	33 California State Teachers Retirement System (CalSTRS) West Sacramento, California	$440K	23,232	+132	+0.6%
34	34 ProShare Advisors Bethesda, Maryland	$385K	20,359	-3,741	-16%
35	TA 35 Teachers Advisors New York	$333K	17,613	–	–
36	HCM 36 Hodges Capital Management Dallas, Texas	$284K	15,000	–	–
37	37 Millennium Management New York	$246K	13,001	+1,601	+14%
38	CS 38 Credit Suisse Zurich, Switzerland	$244K	12,924	-13,362	-51%
39	AL 39 Airain Ltd St. Peter Port, Guernsey	$212K	11,208	+11,208	New
40	40 Bank of Montreal Toronto, Ontario, Canada	$208K	11,000	-2,120	-16%
41	AIG 41 American International Group New York	$207K	10,932	-145	-1%
42	MLICM 42 Metropolitan Life Insurance Company (MetLife) New York	$195K	10,310	+40	+0.4%
43	NFA 43 Nationwide Fund Advisors Columbus, Ohio	$184K	9,724	+113	+1%
44	44 Citigroup New York	$176K	9,289	+254	+3%
45	45 Swiss National Bank Zurich, Switzerland	$142K	7,500	–	–
46	46 AllianceBernstein Nashville, Tennessee	$125K	6,600	+100	+2%
47	BA 47 BlackRock Advisors Wilmington, Delaware	$99K	5,256	-5,842	-53%
48	BAM 48 Brave Asset Management Summit, New Jersey	$99K	5,250	+5,250	New
49	TC 49 Travelers Companies Saint Paul, Minnesota	$79K	4,152	+4,152	New
50	U 50 UBS Zurich, Switzerland	$62K	3,297	-413	-11%

OncoMed Pharmaceuticals, Inc. OMED

Top Buyers

Top Sellers

OncoMed Pharmaceuticals, Inc.

OMED